Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

SpectrumX announces appointment of two new regional sales account managers as it expands its commercial footprint

Published 19/12/2022, 09:55
© Reuters.  SpectrumX announces appointment of two new regional sales account managers as it expands its commercial footprint
GAMA
-

Proactive Investors - SpectrumX Holdings UK Ltd, a UK-based healthcare and pharmaceutical company, has announced the appointment of two new regional sales account managers as the company expands its commercial footprint across the UK, Ireland and Europe.

It said Samantha Gibbons will take charge of South East England, including greater London, and Sarah Ewart will handle England's North East and Scotland. This follows the recent appointment of Sheena Powell as the company's regional account manager for the South West.

The company said Gibbons will be responsible for building commercial relationships, leading sales strategies, and generating growth in the South East and Greater London, the UK’s largest commercial market. Ewart, meanwhile, will lead go-to-market and sales strategies in the region to drive product awareness, create new business opportunities, and provide greater support for clients.

The additions to its sales team come as SpectrumX brings its novel Spectricept product line of broad-spectrum, non-skin-irritant disinfectants to market and supports the company’s plans to grow the business across the UK, Ireland, and continental Europe.

‌Spectricept products, currently consisting of an alcohol-free hand sanitiser and a body wash, are pH-neutral, high-level disinfectants. The active ingredient is the company’s patent-pending, stabilised form of hypochlorous acid (HOCl), effective against bacteria, viruses, fungi, and yeasts on skin.

In the statement announcing Ewart's appointment, Damien Hancox, CEO of SpectrumX, said: “We have been substantially growing our business and see the sales and marketing team as key to this. Sarah is highly experienced in building relationships with NHS Trusts and identifying and developing new accounts, experiences that are of core importance to our team right now. We look forward to working with her as we expand into this key growth area.”

‌Greg Whelan, group sales director at SpectrumX, added: “We are thrilled to welcome Sarah to the team to help expand our business and promote our product line in the North East and Scotland. She brings a wealth of experience to drive that focus.”

Ewart joins SpectrumX from the Medical Defence Union (MDU), where she worked as hospital liaison manager to recruit and retain doctors, deliver medico-legal seminars, and promote the organisation regionally and nationally. Prior to the MDU, she held progressively senior roles as medical sales representative at Pharma Nord UK and area manager at GAMA (LON:GAMA) Healthcare Ltd.

Ewart commented: “I’m delighted join SpectrumX to be a part of its expansion strategy and bring the company’s novel Spectricept products to healthcare facilities in the North East and Scotland for the benefit of workers and patients.”

Read more on Proactive Investors UK

Disclaimer

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.